• SENSEX 78,553.20
    1,508.91 (+1.96%)
  • BANKNIFTY 53,117.75
    738.25 (+1.41%)

IPO

Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing

Beta Drugs Ltd

Beta Drugs Ltd

    Registered Office : Village Nandpur,,Baddi Himachal Pradesh 174101 Phone : 91-1795-236196
    Fax :

    Email : info@betadrugslimited.com

    Website : www.betadrugslimited.com

Public issue of 22,96,000 equity shares of face value of Rs. 10/- each ("equity shares") of Beta Drugs Limited (the "company" Or the "issuer") for cash at a price of Rs. 85/- per equity share, including a share premium of Rs. 75/- per equity share (the "issue price"), aggregating Rs. 19.52 crores ("the issue"), of which 1,29,600 equity shares of face value of Rs. 10/- each for Cash at a price of Rs. 85/- per equity share, aggregating Rs. 1.10 crores will be reserved for subscription by the market Maker to the issue (the "market maker reservation portion"). The issue less market maker reservation portion i.e. Issue of 21,66,400 equity shares of face value of Rs. 10 each for cash at a price of Rs. 85/- per equity share, aggregating Rs. 18.42 crores is hereinafter referred to as the "net issue". The issue and the net issue will constitute 26.54% and 25.05% Respectively of the fully diluted post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10 each and the issue price of Rs. 85 is 8.5 times of the face value of the Equity shares.

Issue

Opens On

Closes On

29-Sep-2017

04-Oct-2017

Money Payable On

Application

Allotment

85.00

0.00

Minimum Application for shares in Nos : 1600.0 Further Multiples of : 1600.0

₹Cr

Lead Managers to the Issue

Project Cost (₹.Cr)

Project Financed through Current Offer (₹.Cr)

Post Issue Equity Share Capital (₹.Cr)

Issue Price (₹.Cr)

19.52

19.52

8.65

85.00

Pantomath Capital Advisors Pvt Ltd

Projects
  • Purchase of new plant and machinery and upgradition of the existing plant and machinery
  • Civil construction work at existing manufacturing plant
  • To obtain registration of european union GMP & Pharmaceutical Inspection Co-operation scheme
  • Working capital
  • General Corporate Purpose
Promoted By
  • Vijay Kumar Batra
Listing At
  • NSE - SME
Registrar to the Issue
  • MUFG Intime India Pvt Ltd